Skip to main content
Premium Trial:

Request an Annual Quote

We Thought that Was a Fair Trade, But Maybe Not

Here's an (unintentionally) entertaining article from Forbes about how compute-intensive genomics is. "People want to live longer, but the cost may be enormous and create fallout in places you never expected," the article reports. "Mapping the human genome and proteins, viewed by many scientists as a first step in prolonging life, is emerging as one of the most compute-intensive tasks in history." Shame on you, Daily Scan readers, for attempting to improve people's lives without regard to how many computer chips get fried in the process!

Our favorite part of the article, though, is this: "They [proponents of genetic research] even anticipate a separate and distinct genomic economy." Maybe it's because we're New Yorkers, but this makes us envision some sort of back-alley black market where people illegally trade genomes.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.